🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
The purpose of this study is to evaluate the impact of an early treatment w...
Status
Completed
Location
Research Site
Start Date
2013-11-12
Trial ID
NCT04832399
Treatments Being Tested
Validating a peptide-based laboratory test enabling the measurement of Tysa...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2016-10
Trial ID
NCT02965170
The purpose of this study is to explore host genetic mutations which may re...
Status
Terminated
Location
North Central Neurology Associates
Start Date
2010-10
Trial ID
NCT01211639
The purpose of the study is to research the association between receiving T...
Status
Completed
Location
Rocky Mountain MS Clinic
Start Date
2012-07
Trial ID
NCT01626248
JC virus is a benign virus which infects approximately up to 90% of the nor...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2010-10
Trial ID
NCT02004444
The MRI scan is one of the most important tools for diagnosing multiple scl...
Status
Completed
Location
Zuyderland MC
Start Date
2023-09-12
Trial ID
NCT05718947
Treatments Being Tested
The primary objective of this study is to assess the efficacy of Ocrelizuma...
Status
Completed
Location
RWJBarnabas Health
Start Date
2017-06-01
Trial ID
NCT03157830
This research study is a Phase II clinical trial, which tests the safety an...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-01
Trial ID
NCT02176031
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of nataliz...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT02142205
Treatments Being Tested